Premium
Psybio Therapeutics Corp (PSYB)
TSXV
Hot Features
Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
NEW YORK, April 29, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced that the presentations from the April 27th and 28th...
NEW YORK, April 25, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, in partnership with KCSA Strategic Communications (“KCSA”), today...
PsyBio Therapeutics Increases Intellectual Property Portfolio with Filing of Novel Genetic Optimization Pathways for Psychedelic Medication Biosynthesis Patent portfolio now includes four pending...
TORONTO, March 04, 2021 (GLOBE NEWSWIRE) -- PsyBio Therapeutics Corp. (TSXV:PSYB) (“PsyBio” or the “Company”), a leader in the field of psychedelic research and drug development, announces that...
OXFORD, Ohio and COCONUT CREEK, Fla., March 02, 2021 (GLOBE NEWSWIRE) -- PsyBio Therapeutics Corp. (TSXV:PSYB) (“PsyBio” or the “Company”), a leader in the field of psychedelic research and drug...
TORONTO, March 01, 2021 (GLOBE NEWSWIRE) -- PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) (TSXV:PSYB) (“PsyBio”), a biotechnology company developing a new class of drugs intended...
TORONTO, Feb. 25, 2021 (GLOBE NEWSWIRE) -- PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) (TSXV: PSYB) (the “Company”) is pleased to announce that at the opening of the market...
Not for distribution to United States newswire services or for release publication, distribution or dissemination directly, or indirectly, in whole or in part, in or into the United States...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0.01 | 0.01 | 0.01 | 0 | 0 | CS |
| 4 | 0 | 0 | 0.01 | 0.01 | 0.01 | 0 | 0 | CS |
| 12 | 0 | 0 | 0.01 | 0.01 | 0.01 | 0 | 0 | CS |
| 26 | 0 | 0 | 0.01 | 0.01 | 0.01 | 0 | 0 | CS |
| 52 | 0 | 0 | 0.01 | 0.01 | 0.01 | 0 | 0 | CS |
| 156 | -0.225 | -95.7446808511 | 0.235 | 0.235 | 0.005 | 58548 | 0.05730002 | CS |
| 260 | -0.74 | -98.6666666667 | 0.75 | 0.9 | 0.005 | 68032 | 0.17354348 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
